Strides Pharma Science Faces Mixed Financial Signals Amid Technical Trend Shift

Apr 08 2025 08:09 AM IST
share
Share Via
Strides Pharma Science has recently experienced a change in its evaluation, reflecting a shift in technical trends. The company reported a notable increase in operating profit, but faces challenges with its long-term fundamentals, including a low Return on Capital Employed and a high Debt to EBITDA ratio.
Strides Pharma Science, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical trend, moving from a mildly bullish stance to a sideways position.

The company's financial metrics present a mixed picture. While Strides Pharma has reported a significant growth in operating profit of 43.26% in December 2024, its long-term fundamentals show challenges. The average Return on Capital Employed (ROCE) stands at 6.00%, indicating limited efficiency in capital utilization. Additionally, the company has experienced a modest annual growth rate in net sales of 8.61% over the past five years, coupled with a high Debt to EBITDA ratio of 6.85 times, which raises concerns about its ability to service debt.

Moreover, the proportion of pledged promoter shares has increased, which can exert additional pressure on stock prices in a declining market. Despite these challenges, Strides Pharma has demonstrated resilience, generating a return of 42.07% over the past year, outperforming the broader market.

For more insights on Strides Pharma Science's financial trends, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News